INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 163 filers reported holding INSMED INC in Q1 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,121 | +19.7% | 84 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,772 | +23.7% | 84 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,432 | -48.4% | 84 | -39.6% | 0.00% | -50.0% |
| Q4 2022 | $2,777 | -7.4% | 139 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | 0.0% | 139 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | -25.0% | 139 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $4,000 | 0.0% | 139 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | 0.0% | 139 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | -20.0% | 139 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $5,000 | -16.7% | 139 | -26.1% | 0.00% | -25.0% |
| Q4 2020 | $6,000 | +20.0% | 188 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $5,000 | -16.7% | 188 | -43.0% | 0.01% | +25.0% |
| Q3 2019 | $6,000 | -33.3% | 330 | -10.6% | 0.00% | -33.3% |
| Q2 2019 | $9,000 | -18.2% | 369 | 0.0% | 0.01% | -25.0% |
| Q1 2019 | $11,000 | +57.1% | 369 | -0.3% | 0.01% | +166.7% |
| Q3 2018 | $7,000 | – | 370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |